Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MITRIC: Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clincal Responders

NCT05286294 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT05286294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05286294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MITRIC: Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clincal Responders
Lead sponsor
Oslo University Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 28, 2022
Completion date
December 31, 2034
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell renal cell carcinoma, cutaneous squamous cell carcinoma, head and neck squamous cell carcinoma, melanoma stage iv, msi-high, non-small cell lung cancer